Table of Contents
Introducing the World Congress on Thyroid Cancer (WCTC)
The World Congress on Thyroid Cancer (WCTC) is a prestigious scientific gathering in the field of thyroid cancer diagnosis and treatment. The event is held in a multidisciplinary format and hosts a wide range of specialists including thyroid surgeons, endocrinologists, oncologists, pathologists and researchers from all over the world. The congress presents and shares the latest research achievements, diagnostic methods and new treatments related to thyroid nodules and cancer.
The first session of the congress was held in Toronto, Canada in 2009. Over the past decade, subsequent sessions of the event have been held in various cities around the world. Among the host cities are Toronto (2013), Boston (2017), Rome 2019 and London (2023). WCTC has gained a global reputation for its comprehensive and advanced scientific program. The congress will feature leading international speakers and experts, and will feature keynote speeches, “Meet the Professor” educational sessions, debates and expert roundtables, and practical workshops. Today, the World Thyroid Cancer Congress is recognized as one of the most influential scientific forums in the field of thyroid diseases, playing a significant role in advancing knowledge and improving treatment methods worldwide.
Dr. Fanaei Invited to Speak at WCTC 2025
The 8th World Thyroid Cancer Congress will be held in Boston, USA, from July 9 to 12, 2025 (Summer 1404). It is an honor that, according to the event secretariat, Dr. Seyed Ahmad Fanaei (a surgeon and thyroid specialist from Iran) has been selected as one of the speakers at WCTC 2025.
Dr. Fanaei’s research paper, titled “The Impact of Genetic Factors on Thyroid Cancer,” has been accepted by the Congress’s Scientific Committee, and he has been invited to present the results of this research to an international audience of experts. The WCTC 2025 Congress is expected to be attended by hundreds of experts from dozens of countries, providing an opportunity to discuss and exchange views on current issues, including the role of genetic factors in thyroid cancer, new surgical methods, and targeted therapies.
This research, which examines the role of genetic factors in the development of thyroid cancer, is one of the most current and important topics in the field of thyroid cancer. For example, recent studies have shown that mutations in certain genes (such as BRAF, RAS, TERT, and RET) can increase the risk of developing thyroid cancer. Understanding such genetic predisposition factors will help doctors better identify individuals at risk and provide more timely and effective treatments. The selection of this research to be presented in the congress program demonstrates the high level of quality and innovation of Dr. Fanaei’s scientific work and provides a valuable opportunity to share his knowledge with global experts.
The honor of representing Iran in the global arena
The selection of Dr. Fanaei as a speaker at a global congress is, in addition to his personal success, a valuable achievement for the Iranian medical community. The presence of an Iranian surgeon among the speakers of this prestigious event demonstrates the high scientific ability of the country’s specialists in the field of thyroid cancer. With more than 20 years of experience and performing more than 5,000 successful thyroid surgeries, Dr. Fanaei is considered one of the leading figures in this field in Iran. It is worth noting that Dr. Fanaei annually participates in global congresses to benefit from the latest scientific achievements in thyroid, and now, by being among the speakers of WCTC 2025, he will share these experiences with the international scientific community. As Iran’s representative at WCTC 2025, Dr. Fanaei will present the country’s scientific achievements and experiences at the international level. This presence will undoubtedly strengthen scientific communication and exchange of the latest achievements between Iran and the international community. Ultimately, reflecting these valuable experiences will help improve healthcare for thyroid cancer patients in the country.
Details to be provided after the congress
Finally, it should be noted that the full text of Dr. Fanai’s speech and details of his presentation at WCTC 2025 will be available to interested parties via this website after the event. We congratulate Dr. Fanai again on this honor, wish him success, and look forward to publishing the full report of this international presence.
No comment